Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
11/2008
11/12/2008EP1988886A1 Delayed release pharmaceutical oral dosage form and method of making same
11/12/2008EP1472278B1 Macrocyclic peptides active against the hepatitis c virus
11/12/2008EP1404305B1 Pharmacological preparation made from a nanoparticulate mesomorphous polyelectrolyte lipid complex and at least one active ingredient
11/12/2008EP1343503B1 Heteroaryl urea neuropeptide y y5 receptor antagonists
11/12/2008EP1055426B1 Dysuria remedies
11/12/2008EP0944647B1 Submucosa extracts
11/12/2008EP0792359B1 Transcription factor e2f-4
11/12/2008CN101304762A Compositions and methods for treating or preventing flaviviridae infections
11/12/2008CN101304736A IKK inhibitors for the treatment of endometriosis
11/12/2008CN101302182A Virus polymerase inhibitors
11/12/2008CN101301472A Anticancer composition containing taxane medicament and bortezomib
11/12/2008CN101301471A Anticancer composition containing antimetabolism medicament and bortezomib
11/12/2008CN101301470A Anticancer composition containing neovascularization inhibitor and bortezomib
11/12/2008CN101301469A Anticancer composition containing nitrosourea medicament and bortezomib
11/12/2008CN101301294A Combinated inhibitors of FBP-ase and antidiabetic agents for diabetes treatment
11/12/2008CN101301266A Anticancer gel sustained-release injection containing alkyl agent
11/12/2008CN101301265A Dual sustained-release anticancer gel injection
11/12/2008CN101301264A Dual sustained-release anticancer injection
11/12/2008CN100431609C Long circulation liposome with modified integrin and carried anticancer medicine for injection
11/12/2008CN100431608C Anti entity tumour medicinal composition containing tetrazine kind compound
11/12/2008CN100431607C Medicinal composition for tumor body
11/12/2008CN100431606C Anti-cancer medicine composition
11/12/2008CN100431605C Anticarcinogen composition
11/12/2008CN100431553C Composition for improving obstacle under pharynx
11/12/2008CN100431545C Use of compositions comprising an estrogenic component for the treatment and prevention of musculoskeletal pain
11/12/2008CN100431543C Pharmaceutical composition
11/12/2008CN100431515C Method for preparing additive of stable micronized medication
11/11/2008US7449613 Film-forming compositions for protecting skin from body fluids and articles made therefrom
11/11/2008US7449548 Nucleic acid and corresponding protein entitled 193P1E1B useful in treatment and detection of cancer
11/11/2008US7449545 Antimicrobial bolisin peptides
11/11/2008US7449495 e.g. 4-(3-(1-Adamantyl)-4-tert-butyldimethyl-silyloxyphenyl)benzaldehyde; antitumor, antiinflammatory agent; arthritic pathology, metastatisation, diabetic retinopathy, psoriasis, chronic inflammatory disease, and atherosclerosis; sarcoma, carcinoma, carcinoid, leukaemia
11/11/2008US7449479 Hepatitis C virus inhibitors
11/11/2008US7449198 Stable salts of O-acetylsalicylic acid with basic amino acids
11/11/2008US7449190 Assays for assembly of Ebola virus nucleocapsids
11/11/2008US7449185 Immunoglobulin which binds osteoclastogenesis inhibitory factor binding molecules (OBM)) and prevents bone resorption for use in treatment and prevention of bone disorders
11/11/2008US7449176 Treatment of inflammatory bowel disease with IFN-γ inhibitors
11/11/2008US7449175 Delivery of erectile dysfunction drugs through an inhalation route
11/11/2008US7449174 Delivery of analgesics through an inhalation route
11/11/2008US7449172 Delivery of antiemetics through an inhalation route
11/06/2008WO2008134694A1 N-halogenated amino acid formulations and methods for cleaning and disinfection
11/06/2008WO2008134692A1 Aliphatic acid-containing n-halogenated amino acid formulations
11/06/2008WO2008134687A1 N-halogenated amino acid formulations
11/06/2008WO2008133983A1 Adjuvant combinations of nkt activator, cd40 agonist, and optional antigen, the use through inducing synergistic cellular immunity
11/06/2008WO2008133772A1 Method for modulating activity of t lymphocytes
11/06/2008WO2008133292A1 Disease-related protein for scirrhous cancer
11/06/2008WO2008133128A1 Fused heterocyclic derivative, pharmaceutical composition comprising the derivative, and use of the composition for medical purposes
11/06/2008WO2008133036A1 Method for screening of therapeutic agent for renal tubular dysfunction
11/06/2008WO2008132712A2 Combination pharmaceutical compositions
11/06/2008WO2008132500A2 Chkl inhibitors with b cell depleting antibodies for the treatment of hematologic malignancies
11/06/2008WO2008132239A1 Pharmaceutical composition comprising at least one thrombolytic agent (a) and at least one gas (b) selected from the group consisting of nitrous oxide, argon, xenon, helium, neon
11/06/2008WO2008131940A2 Combination of immunological agent and sensitizing agent for the treatment of cancer
11/06/2008WO2008113149A3 Observations where certain claims were found unsearchable
11/06/2008WO2008067351A3 Method of diagnosing and treating glioma
11/06/2008WO2008063650A3 Systems of hydrogen and formic acid production in yeast
11/06/2008WO2008020306A3 Isoindole derivatives
11/06/2008US20080275272 Amine compounds and inhibiting neurotransmitter reuptake
11/06/2008US20080275108 VACUOLAR-TYPE (H+)-ATPase-INHIBITING COMPOUNDS, COMPOSITIONS, AND USES THEREOF
11/06/2008US20080275095 Packages
11/06/2008US20080275089 Compositions and methods to treat gastrointestinal disorders
11/06/2008US20080275081 Novel thrombomodulin expression promoters
11/06/2008US20080275080 Methods for treating lower urinary tract disorders using alpha2delta subunit channel modulators with smooth muscle modulators
11/06/2008US20080275075 Medicine Comprising a Combination of an Acetylcholinesterase Inhibitor and a 5-Substituted-3-Oxadiazolyl-1,6-Naphthyridin-2(1H)-One Derivative
11/06/2008US20080275034 having a calpain inhibiting activity and an activity which traps the reactive oxygen species (ROS); for protecting acoustic hair cells;
11/06/2008US20080275020 Pharmaceutical formulation
11/06/2008US20080275011 Synergistic mixture; mycardial infraction; cardiovascular disorders
11/06/2008US20080275010 Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
11/06/2008US20080274954 Novel protein; rho genes rho proteins; guanosine triphosphate binding proteins; antibody against the protein encodes polynucleotide; detection; determinating esophagual cancer
11/06/2008US20080274490 Using protein tyrosine phosphatase (SHP-2) as tool in identifying compounds which modulate the activity of programed death-1 (PD-1); treating autoimmune, nervous system, tumor and immunosuppressive disorders
11/06/2008US20080274468 Novel means for the diagnosis and therapy of ctcl
11/06/2008US20080274159 Drug formulations for coating medical devices
11/06/2008US20080274153 Use of Emu Oil and its various fractions as a carrier for antifungal, antibacterial, and antiviral medications & preparations
11/06/2008US20080274107 Tyrosine kinase inhibitors
11/06/2008US20080274106 Using interleukin-6 specific monoclonal antibody as therapeutic in treatment and prevention of lung cancer
11/06/2008US20080274045 Imaging, diagnosis and treatment of disease
11/06/2008CA2688718A1 Biocidic packaging for cosmetics and foodstuffs
11/06/2008CA2685593A1 Combination pharmaceutical compositions
11/06/2008CA2685446A1 Pharmaceutical composition comprising at least one thrombolytic agent (a) and at least one gas (b) selected from the group consisting of nitrous oxide, argon, xenon, helium, neon
11/06/2008CA2685125A1 Adjuvant combinations comprising an nkt activator, a cd40 agonist, and optionally an antigen and use thereof for inducing a synergistic enhancement in cellular immunity
11/06/2008CA2684185A1 N-halogenated amino acid formulations and methods for cleaning and disinfection
11/06/2008CA2684101A1 Aliphatic acid-containing n-halogenated amino acid formulations
11/06/2008CA2684098A1 N-halogenated amino acid formulations
11/06/2008CA2682400A1 Fused heterocyclic derivative, pharmaceutical composition comprising the derivative, and use of the composition for medical purposes
11/05/2008EP1988171A1 Substance fki-2342 and process for production thereof
11/05/2008EP1988165A1 Isolated DNA encoding cullin regulator ROC1, isolated proteins encoded by the same, and methods utilizing the same
11/05/2008EP1988164A1 Method of testing sensitivity of solid cancer against tyrosine kinase inhibitor and test kit therefor
11/05/2008EP1988102A1 Growth factor homolog ZVEGF3
11/05/2008EP1988097A1 Compositions and methods for the therapy and diagnosis of prostate cancer
11/05/2008EP1987842A1 Cell proliferation inhibitor
11/05/2008EP1987823A1 Condensation aerosol containing zaleplon for inhalation
11/05/2008EP1986952A2 Methods of treating cystic fibrosis
11/05/2008EP1986691A2 Antimicrobial formulations comprising a quinone and a copper salt
11/05/2008EP1986656A2 Withacnistin compounds for treatment of cancer
11/05/2008EP1986642A1 Combination of alpha-2 receptor agonist (clonidin) and an anti-muscarinic agent (oxybutynin) for the treatment of sialorrhoea
11/05/2008EP1986639A2 Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of depression, anxiety, and neurodegenerative disorders
11/05/2008EP1986627A2 Use of a compound that enhances gabaa-ergic neurotransmission for the treatment of inflammatory diseases
11/05/2008EP1986624A2 Method of using abscisic acid to treat and prevent diseases and disorders
11/05/2008EP1664275A4 In vivo synthesis of connective tissues
11/05/2008EP1605924B1 Mesoprogestins (progesterone receptor modulators) as a component of compositions for hormone replacement therapy (hrt)
11/05/2008EP1534276B1 Non-nucleoside reverse transcriptase inhibitors
11/05/2008EP1372671B1 Methylation modulating agents for intraductal treatment of breast cancer
1 ... 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 ... 1151